Kinins IV pp 397-404 | Cite as

Vascular, Post Proline Cleaving Enzyme: Metabolism of Vasoactive Peptides

  • Hester H. Bausback
  • Patrick E. Ward
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 198A)


Vasoactive peptides contain a high proportion of proline residues which make them resistant to hydrolysis by many peptidases. However, post proline cleaving enzyme (PPCE; EC, a proline specific endopeptidase which specifically hydrolyzes internal peptide bonds on the carboxyl side of proline residues, has been shown to inactivate numerous vasoactive peptides including angiotensins, kinins, substance P, vasopressin and oxytocin. In order to determine whether PPCE could be involved in vascular metabolism of vasoactive peptides, we carried out localization and characterization studies of PPCE-like activity in hog aorta and mesenteric artery. PPCE was assayed fluorometrically at pH 7.0 using the specific PPCE substrate CBZ-Gly-Pro-4-methyl-coumarinylamide. The subcellular distribution of vascular PPCE was essentially the same as that of the cytosolic marker enzyme lactic dehydrogenase (LDH). PPCE was enriched six-fold in the cytosolic fraction (11.4 ± 2.7 units/mg) and, unlike the plasma membrane-bound proline specific exopeptidase dipeptidyl-(amino) peptidase IV (DAP IV; EC, little or no activity could be detected in the microsomal or plasma membrane fractions. Similar to PPCE characterized from other sites, vascular PPCE was stabilized and activated by dithiothreitol and EDTA, and inhibited by DFP, p-chloromercuriphenyl sulfonic acid, L-1-tosylamido-2- phenylethylchloromethyl ketone, Cu++, Ca++, and Zn++. Vascular PPCE was unaffected by inhibitors of trypsin and kallikrein (Aprotinin, ABTI), aminopeptidase M (bestatin, amastatin), neutral endopeptidase (phosphoramidon), angiotensin I converting enzyme (captopril) or carboxypeptidase N (MERGETPA). These data demonstrate that PPCE is present in vascular endothelium and/or smooth muscle. Although PPCE may participate in vascular metabolism of vasoactive peptides, its cytosolic localization and endopeptidase specificity suggests that its role is limited to peptide degradation after transport into the cell.


Proline Residue Plasma Membrane Fraction Neutral Endopeptidase Vasoactive Peptide Immunoelectrophoretic Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. L. Soffer, Angiotensin I converting enzyme and the regulation of vasoactive peptides, Ann. Rev. Biochem., 45: 73–94 (1976).CrossRefGoogle Scholar
  2. 2.
    U. S. Ryan, J. W. Ryan, C. Whitaker, and A. Chiu, Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence, Tissue Cell, 8: 125–146 (1976).PubMedCrossRefGoogle Scholar
  3. 3.
    P. E. Ward, Immunoelectrophoretic analysis of vascular, membrane bound angiotensin I converting enzyme, aminopeptidase M, and dipeptidyl (amino)peptidase IV, Biochem. Pharmacol., 33: 3183–3193 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    F. E. Palmieri, J. J. Petrelli, and P. E. Ward, Vascular, plasma membrane aminopeptidase M: Metabolism of vasoactive peptides, Biochem. Pharmacol. (In press).Google Scholar
  5. 5.
    F. E. Palmieri and P. E. Ward, Mesentery vascular metabolism of substance P, Biochim. Biophys. Acta, 755: 522–525 (1983).CrossRefGoogle Scholar
  6. 6.
    A. J. Kenny and A. G. Booth, Microvilli: Their ultrastructure, enzymology and molecular organization, Essays Biochem., 14: 1–44 (1978).PubMedGoogle Scholar
  7. 7.
    E. Heymann and R. Mentlein, Liver dipeptidyl aminopeptidase IV hydrolyzes substance P, FEBS Lett., 91: 360–364 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    T. Kato, T. Nagatsu, K. Fukasawa, M. Harada, I. Nagatsu, and S. Sakakibara, Successive cleavage of N-terminal Argl-Pro2 and Lys 3-Pro4 from substance P but no release of Argl-Pro2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase, Biochim. Biophys. Acta, 525: 417–422 (1978).CrossRefGoogle Scholar
  9. 9.
    R. Walter, W. H. Simmons, and T. Yoshimoto, Proline specific endo- and exopeptidases, Mol. Cell. Biochem., 30: 111–127 (1980).CrossRefGoogle Scholar
  10. 10.
    H. Shlank and R. Walter, Enzymic cleavage of post proline peptide bonds: Degredation of arginine-vasopressin and angiotensin II, Proc. Soc. Exp. Biol. Med., 141: 452–455 (1972).PubMedGoogle Scholar
  11. 11.
    L. B. Hersh, Immunological, physical and chemical evidence for the identity of brain and kidney post-proline cleaving enzyme, J. Neurochem., 37: 172–178 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    C. Y. Kwan, R. Garfield, and E. E. Daniel, An improved procedure for the isolation of plasma membranes from rat mesenteric arteries, J. Mol. Cell. Cardiol., 11: 639–659 (1979).PubMedCrossRefGoogle Scholar
  13. 13.
    T. Yoshimoto, K. Ogita, R. Walter, M. Koida, and D. Tsuru, Post proline cleaving enzyme. Synthesis of a new fluorogenic substrate and dis-tribution of the endopeptidase in rat tissues and body fluids of man, Biochim. Biophys. Acta, 569: 184–192 (1979).CrossRefGoogle Scholar
  14. 14.
    O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with folin phenol reagent, J. Biol. Chem., 193: 265–275 (1951).Google Scholar
  15. 15.
    G. Toennies and J. J. Kolb, Techniques and reagents for paper chromatography, Anal. Chem., 23: 823–826 (1951).CrossRefGoogle Scholar
  16. 16.
    J. Almenoff and M. Orlowski, Membrane bound neutral metalloendopeptidase: Interaction with synthetic substrates, natural peptides and inhibitors, Biochemistry, 22: 590–599 (1983).PubMedCrossRefGoogle Scholar
  17. 17.
    T. H. Plummer and T. J. Ryan, A potent mercapto bi-product analogueinhibitor for human carboxypeptidase N, Biochim. Biophys. Res. Commun., 98:448–454 (1981).Google Scholar
  18. 18.
    J. Hughes, Biogenesis, release and inactivation of enkephalins and dynorphins, Brit. Med. Bull., 39:17–24 (1983).Google Scholar
  19. 19.
    P. E. Ward and M. A. Sheridan, Immunoelectrophoretic analysis of renal and intestinal brush border converting enzyme, Biochem. Pharmaco1., 32:265–274 (1983).Google Scholar
  20. 20.
    T. Kato, M. Okada, and T. Nagatsu, Distribution of post proline cleaving enzyme in human brain and the peripheral tissues, Mol. Cell. Biochem., 32:117–121 (1980).Google Scholar
  21. 21.
    J. Magnan and D. Regoli, Metabolism of angiotensin II and some analogs in intact strips and in muscle preparations of rabbit aortae, Can. J. Physiol. Pharmacol., 56:39–47 (1978).Google Scholar
  22. 22.
    F. Marceau, M. Gendreau, J. Barabe, S. St-Pierre, and D. Regoli, The degredation of bradykinin and of des-Arg9-bradykinin in plasma, Can. J. Physiol. Pharmacol., 59:131–138 (1981).Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Hester H. Bausback
    • 1
  • Patrick E. Ward
    • 1
  1. 1.Department of PharmacologyNew York Medical CollegeValhallaUSA

Personalised recommendations